🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

FDC vs SANOFICONR: Stock Comparison

FDC vs SANOFI CONS HEALTHC IND LUpdated 30 Oct 26, 11:20 AM ISTNSE & company filings

SANOFI CONS HEALTHC IND L is the larger company by market capitalisation. FDC shows a lower P/E and a higher dividend yield, while SANOFI CONS HEALTHC IND L shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FDC leads 4; SANOFICONR leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FDCSANOFICONR

Valuation lens

What price are you paying?

Market CapContext only
₹6,171 Cr
₹7,795 Cr
P/E RatioFDC has the lower reading
19.53x ✓
28.64x
P/B RatioFDC has the lower reading
2.3x ✓
23.02x
EPSSANOFICONR has the higher reading
₹19.24
₹29.87 ✓
Book ValueContext only
₹163.75
₹166.73
Dividend YieldFDC has the higher reading
2.66% ✓
2.16%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SANOFICONR is the larger company
₹7,795 Cr vs ₹6,171 Cr
P/E Ratio
FDC has a lower P/E
19.53x vs 28.64x
P/B Ratio
FDC has a lower P/B
2.3x vs 23.02x
EPS
SANOFICONR has higher earnings per share
₹29.87 vs ₹19.24
Dividend Yield
FDC has a higher dividend yield
2.66% vs 2.16%
Revenue Growth (TTM YoY)
SANOFICONR has faster revenue growth
32.8% vs 18.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs 35.7%
Qtr Sales Growth
SANOFICONR has stronger quarterly sales growth
2.84% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCSANOFICONR
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCSANOFICONR
Live Price₹379₹3,370.7
Day Change0.49%-2.81%
Volume1.1 L14,681
52-Week High₹473.6₹5,255
52-Week Low₹312.95₹3,168.2
Distance from 52W High-19.97%-35.86%

Valuation

MetricFDCSANOFICONR
Market Cap₹6,171 Cr₹7,795 Cr
P/E Ratio19.53x28.64x
P/B Ratio2.3x23.02x
EPS₹19.24₹29.87
Book Value₹163.75₹166.73
Dividend Yield2.66%2.16%

Growth

MetricFDCSANOFICONR
Revenue Growth (TTM YoY)18.9%32.8%
EPS Growth (TTM YoY)166.8%35.7%
Qtr Sales Growth0%2.84%
Qtr Profit Growth0%1.47%

Profitability & Leverage

MetricFDCSANOFICONR
ROE11.47%67.16%
ROCE11.69%2,813.76%
Net Margin12.96%27.58%
Operating Margin18.03%37.04%
Debt to Equity0x0x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricFDCSANOFICONR
Promoter Holding69.66%71.27%
FII Holding1.58%▲ 0.18 pp2.48%▼ 0.12 pp
DII Holding6.59%▲ 0.28 pp18.03%▲ 0.17 pp
Public Holding22.17%▼ 0.46 pp8.22%▼ 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC and SANOFI CONS HEALTHC IND L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.